Bottom line
What is SCHLX's expense ratio?
SCHLX's expense ratio is 1.06%, or about $106 a year on every $10,000 invested. That is more expensive than 61% of health care sector funds we track (median 0.96%). It has no front-end sales load.
Updated Sep 24, 2026
SCHLX fee table
| Net expense ratio | 1.06% |
|---|---|
| Gross expense ratio | 1.06% |
| Management fee | 0.77% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.29% |
| Fee waiver / reimbursement | 0% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Sep 24, 2026
What SCHLX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| SCHLX | $108 | $337 | $585 | $1,294 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.06% expense ratio costs roughly $58,400 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).
Cheaper alternatives to SCHLX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.